Current Edition

news

Lilly claims promising finding in failed study of COVID-19 drug

Dive Brief: Treatment with a repurposed arthritis drug from Eli Lilly and Incyte did not significantly lessen the risk of worsening disease among people hospitalized …

Continue Reading →
news

With new data, Merck could be first to bring immunotherapy to early kidney cancer

Dive Brief: Merck & Co.’s Keytruda has succeeded in a Phase 3 trial in early kidney cancer, the drugmaker announced Thursday, in the latest example …

Continue Reading →
news

Biogen adds a late-stage prospect to its growing biosimilar business

Dive Brief: Biogen has secured exclusive rights to develop, manufacture and sell an experimental copycat version of Actemra, the blockbuster anti-inflammatory drug which recently came …

Continue Reading →
news

Gilead wins full approval for drug acquired in Immunomedics deal

Dive Brief: Gilead has secured full Food and Drug Administration approval for its breast cancer treatment Trodelvy, less than a year after the agency cleared …

Continue Reading →
news

AstraZeneca’s coronavirus vaccine possibly linked to rare blood clots, EMA says

Dive Brief: The European Medicines Agency on Wednesday confirmed a “possible link” between AstraZeneca’s coronavirus vaccine and dozens of cases of abnormal blood clots that …

Continue Reading →